Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Changes in CO2 concentration increase the invasive ability of colon cancer cells.

Obata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A.

Anticancer Res. 2013 May;33(5):1881-5.

PMID:
23645734
2.
3.

Protein-bound polysaccharide K reduced the invasive ability of colon cancer cell lines.

Uwafuji S, Goi T, Naruse T, Kurebayashi H, Nakazawa T, Hirono Y, Yamaguchi A.

Anticancer Res. 2013 Nov;33(11):4841-5.

PMID:
24222121
4.

CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.

Hirai H, Fujishita T, Kurimoto K, Miyachi H, Kitano S, Inamoto S, Itatani Y, Saitou M, Maekawa T, Taketo MM.

Clin Exp Metastasis. 2014 Dec;31(8):977-89. doi: 10.1007/s10585-014-9684-z. Epub 2014 Oct 18.

5.

Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.

Tabata S, Goi T, Nakazawa T, Kimura Y, Katayama K, Yamaguchi A.

Oncol Rep. 2013 Feb;29(2):459-63. doi: 10.3892/or.2012.2124. Epub 2012 Nov 6.

PMID:
23135359
6.

Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.

Papi A, Bartolini G, Ammar K, Guerra F, Ferreri AM, Rocchi P, Orlandi M.

Oncol Rep. 2007 Oct;18(4):1015-21.

PMID:
17786368
7.

Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.

Kaneko F, Saito H, Saito Y, Wakabayashi K, Nakamoto N, Tada S, Suzuki H, Tsunematsu S, Kumagai N, Ishii H.

Int J Oncol. 2004 Apr;24(4):837-45.

PMID:
15010820
8.

Heated and humidified CO₂ pneumoperitoneum inhibits tumour cell proliferation, migration and invasion in colon cancer.

Cai W, Dong F, Wang Z, Yang X, Zheng M, Che X.

Int J Hyperthermia. 2014 May;30(3):201-9. doi: 10.3109/02656736.2014.898339. Epub 2014 Apr 10.

PMID:
24720439
9.

Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.

Zhang J, Wang B.

Gynecol Oncol. 2006 Oct;103(1):199-206. Epub 2006 Apr 19.

PMID:
16624393
11.

RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.

Wang B, Xu YF, He BS, Pan YQ, Zhang LR, Zhu C, Qu LL, Wang SK.

J Exp Clin Cancer Res. 2010 Jun 3;29:61. doi: 10.1186/1756-9966-29-61.

12.

[Effects of allicin on invasion and metastasis of colon cancer LoVo cell line in vitro].

Gao Y, Liu YQ, Cao WK, Chen XF, Wan YY, Heng C, Xu LJ.

Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1382-6. Chinese.

PMID:
19671326
13.

Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.

Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2013 May;33(5):1927-34.

PMID:
23645740
14.

Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.

Chu ES, Sze SC, Cheung HP, Wong KL, Liu Q, Ng TB, Tong Y.

J Ethnopharmacol. 2011 Sep 1;137(1):403-13. doi: 10.1016/j.jep.2011.05.035. Epub 2011 Jun 6.

PMID:
21669277
15.

Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.

Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C.

PLoS One. 2011;6(11):e27339. doi: 10.1371/journal.pone.0027339. Epub 2011 Nov 4.

16.

Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways.

Babykutty S, Suboj P, Srinivas P, Nair AS, Chandramohan K, Gopala S.

Clin Exp Metastasis. 2012 Jun;29(5):471-92. doi: 10.1007/s10585-012-9464-6. Epub 2012 Mar 15.

PMID:
22419013
17.

Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB.

Suboj P, Babykutty S, Valiyaparambil Gopi DR, Nair RS, Srinivas P, Gopala S.

Eur J Pharm Sci. 2012 Apr 11;45(5):581-91. doi: 10.1016/j.ejps.2011.12.012. Epub 2011 Dec 30.

PMID:
22227305
18.

Tyroservatide therapy for tumor invasion and metastasis of human ovarian carcinoma and colon carcinoma.

Wang L, Che X, Li X, Lv J, Zhou C, Wang S, Zhu Z, Wang L, Lin G, Lu R, Yao Z.

Anticancer Drugs. 2012 Nov;23(10):1067-77.

PMID:
22922208
19.

An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.

You J, Madigan MC, Rowe A, Sajinovic M, Russell PJ, Jackson P.

Urol Oncol. 2012 Jul-Aug;30(4):502-8. doi: 10.1016/j.urolonc.2010.02.013. Epub 2010 Sep 22.

PMID:
20864363
20.

Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.

Lee JC, Maa MC, Yu HS, Wang JH, Yen CK, Wang ST, Chen YJ, Liu Y, Jin YT, Leu TH.

Mol Carcinog. 2005 Aug;43(4):207-14.

PMID:
16001424

Supplemental Content

Support Center